Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants

Shuijing Wang, Yan Yu, Paul M. Ryan, Minyan Dang, Cain Clark, Vasileios Kontogiannis, Jamal Rahmani, Hamed Kord Varkaneh, Ammar Salehisahlabadi, Andrew S. Day, Yong Zhang*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    36 Citations (SciVal)
    Original languageEnglish
    Article number104585
    JournalPharmacological Research
    Volume151
    DOIs
    Publication statusPublished (VoR) - Jan 2020

    Keywords

    • Aspirin
    • Hepatocellular carcinoma
    • Liver cancer

    Fingerprint

    Dive into the research topics of 'Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants'. Together they form a unique fingerprint.

    Cite this